Early distant relapse after optimal local control in locally advanced rectal cancer

International Seminars in Surgical Oncology

Volumn 5, Issue , 2008, Pages

  Gallego Plazas, Javier ^a   Menarguez Pina, Francisco ^b   Martinez Banaclocha, Natividad ^a   Pons Sanz, Vanesa ^a   Mingol Navarro, Fernando ^a   Ruiz Macia, Jose A ^b   Macia Escalante, Sonia ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

^b HOSPITAL VEGA BAJA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CA 19-9 ANTIGEN; CAPECITABINE; CARCINOEMBRYONIC ANTIGEN; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

ADENOMATOUS POLYP; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; ADVANCED CANCER; ANEMIA; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER STAGING; CASE REPORT; CLINICAL FEATURE; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; CYSTITIS; ENDOSCOPIC ECHOGRAPHY; GOUT; HEMORRHOID; HUMAN; HYPERURICEMIA; LIVER METASTASIS; LIVER RESECTION; MALE; MULTIPLE CYCLE TREATMENT; RECTUM ABDOMINOPERINEAL RESECTION; RECTUM CARCINOMA; RECTUM HEMORRHAGE; RECTUM TUMOR; SIGMOID; TREATMENT RESPONSE; TUMOR BIOPSY; TUMOR LOCALIZATION;

EID: 48249104310     PISSN: None     EISSN: 14777800     Source Type: Journal    
DOI: 10.1186/1477-7800-5-18     Document Type: Article

References (18)

1. Yerushalmi R Idelevich E Dror Y Stemmer SM Figer A Sulkes A Brenner B Loven D Dreznik Z Nudelman I Shani A Fenig E Preoperative chemoradiation in rectal cancer: Retrospective comparison between capecitabine and continuous infusion of 5-fluorouracil J Surg Oncol 2006, 93:529-533. 10.1002/jso.20503 16705722
2. Mandard AM Dalibard F Mandard JC Marnay J Henry-Amar M Petiot JF Roussel A Jacob JH Segol P Samama G Pathologic assessment of tumour regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations Cancer 1994, 73:2680-2686. 10.1002/ 1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C 8194005
3. Wolmark N Rockette H Mamounas E Jones J Wieand S Wickerham DL Bear HD Atkins JN Dimitrov NV Glass AG Fisher ER Fisher B Clinical trial to asses the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin and levamisole in patients with Dukes B and C carcinoma of the colon: Results from the NSABP C-04 J Clin Oncol 1999, 17(11):3553-3559. 10550154
4. Collette L Bosset JF den Dulk M Nguyen F Mineur L Maingon P Radosevic-Jelic L Piérart M Calais G European Organisation for Research and Treatment of Cancer Radiation Oncology Group Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or chemoradiotherapy: Does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European organisation for research and Treatment of cancer radiation oncology group J Clin Oncol 2007, 25(28):4379-4386. 10.1200/JCO.2007.11.9685 17906203
5. Locker GY Hamilton S Harris J Jessup JM Kemeny N Macdonald JS Somerfield MR Hayes DF Bast RC Jr ASCO ASCO 2006 Update of recommendations for the use of tumor markers in gastrointestinal cancer J Clin Oncol 2006, 24(33):5313-5327. 10.1200/JCO.2006.08.2644 17060676
6. Joyce DL Wahl RL Patel PV Schulick RD Gearhart SL Choti MA Preoperative positron emission tomography to evaluate potentially respectable hepatic colorectal metastases Arch Surg 2006, 141(12):1220-1226. 10.1001/ archsurg.141.12.1220 17178965
7. Nordlinger B Sorbye H Glimelius B Poston GJ Sclag PM Rougier P Bechstein WO Primrose JN Walpole ET Finch-Jones M Jaeck D Mirza D Parks RW Collette L Praet M Bethe U Van Cutsem E Scheihauer W Gruenberger T for the EORTC Gastro-Intestinal Tract Cancer Group, Cancer Research UK, Arbeitsgruppe Lebermetastasen und-tumoren in der Chirurgischen Arbeitsgemeinschaft Onkologie (ALM-CAO), Australasian Gastro-Intestinal Trials Group (AGITG), and Fedération Francophone de Cancérologie Digestive (FFCD) Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): A randomised controlled trial Lancet 2008, 371(9617):1007-1016. 2277487 18358928 10.1016/S0140-6736(08)60455-9
8. Sauer R Becker H Hohenberger W Rödel C Wittekind C Fietkau R Martus P Tschmelitsch J Hager E Hess CF Karstens JH Liersch T Schmidberger H Raab R German Rectal Cancer Study Group Preoperative versus postoperative chemoradiotherapy for rectal cancer N Eng J Med 2004, 351:1731-1740. 10.1056/NEJMoa040694
9. Bosset JF Calais G Mineur L Maingon P Radosevic-Jelic L Daban A Bardet E Beny A Ollier JC Collette L Preoperative radiation in rectal cancer. Effect and timing of additional chemotherapy 5-year results of the EORTC 22291 trial J Clin Oncol 2005, 16S:3505. (abstr)
10. Gerard JP Conroy T Bonnetain F Bouché O Chapet O Closon-Dejardin MT Untereiner M Leduc B Francois E Maurel J Seitz JF Buecher B Mackiewicz R Ducreux M Bedenne L Preoperative radiotherapy with or without fluorouracil and leucovorin in T3-4 rectal cancers. results of FFCD 9203 trial J Clin Oncol 2006, 24(28):4620-4625. 10.1200/ JCO.2006.06.7629 17008704
11. Chau I Brown G Cunningham D Tait D Wotherspoon A Norman AR Tebbut N Hill M Ross PJ Massey A Oates J Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer J Clin Oncol 2006, 24:668-674. 10.1200/JCO.2005.04.4875 16446339
12. Saunders M Iveson T Management of advanced colorectal cancer: State of the art Br J Cancer 2006, 95:131-138. 10.1038/sj.bjc.6603233 16835584
13. Saltz L Clarke S Díaz-Rubio E Schiethauer W Figer A Wong R Koski S Lichinitser M Yang T Cassidy J Bevacizumab in combination with XELOX or FOLFOX 4: Updated efficacy results from XELOX-1/N016966, a randomized pahse III trial in first-line metastatic colorectal cancer J Clin Oncol 2007, 18S(suppl):4028. (abstr)
14. Van Cutsem E Nowacki M Lang I Cascinu S Shchepotin I Maurel J Rougier P Cunningham D Nippgen J Köhne C Randomized phase III study of irinotecan and fluorouracul/FA with or without cetuximab in the first-line treatment of patients with metastatic colorectal cancer: The CRYSTAL trial J Clin Oncol 2007, 18S(suppl):4000. (abstr)
15. Falcone A Ricci S Brunetti I Pfanner E Allegrini G Barbara C Crinò N Benedetti G Evangelista W Fanchini L Cortesi E Picone V Vitello S Chiara S Granetto C Porcile G Fioretto L Orlandini C Andreuccetti M Masi G Gruppo Oncologico Nord Ovest Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecn (FOLFIRI) as first line treatment for metastatic colorectal cancer: The Gruppo Oncologico Nord Ovest J Clin Oncol 2007, 25(13):1670-1676. 10.1200/JCO.2006.09.0928 17470860
16. Leonard GD Brenner B Kemeny NE Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma J Clin Oncol 2005, 23:2038-2048. 10.1200/ JCO.2005.00.349 15774795
17. Bilchik AJ Poston G Curley SA Strasberg S Saltz L Adam R Nordlinger B Rougier P Rosen LS Neoadjuvant chemotherapy for metastatic colon cancer: A cautionary note J Clin Oncol 2005, 23:9073-9078. 10.1200/ JCO.2005.03.2334 16361615
18. Benoist S Brouquet A Penna C Julié C El Hajjam M Chagnon S Mitry E Rougier P Nordlinger B Complete response of colorectal liver metastases after chemotherapy: Does it mean cure? J Clin Oncol 2006, 24:3939-3945. 10.1200/JCO.2006.05.8727 16921046